Form 4: DENTSPLY SIRONA Director Boosts Equity Holdings

DENTSPLY SIRONA Director Jonathan Jay Mazelsky acquired additional common stock and phantom stock through dividend reinvestment.

Summary

• Director Jonathan Jay Mazelsky acquired 359.576 shares of DENTSPLY SIRONA Inc. common stock on October 10, 2025.
• These common shares represent dividends on restricted stock units (RSUs) and were acquired at a price of $0, subject to the same vesting terms as the underlying awards.
• Mazelsky also acquired 123.3618 shares of phantom stock on October 10, 2025, which represent accrued dividends, at a price of $11.98 per share.
• Following these transactions, Mazelsky directly owns 28,451.376 shares of common stock and 11,743.5642 shares of phantom stock.
• Each share of phantom stock is the economic equivalent of one share of common stock and becomes payable in common stock upon the reporting person's termination of service as a director.

Sentiment

Score: 7

Explanation: The director's increased beneficial ownership through dividend reinvestment indicates continued confidence and alignment with shareholder interests, which is a positive signal.

Positives

• Director Jonathan Jay Mazelsky increased his beneficial ownership in DENTSPLY SIRONA Inc. through the acquisition of additional common stock and phantom stock.
• The acquisition of shares through dividend reinvestment demonstrates continued alignment of the director's interests with those of shareholders.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The increased beneficial ownership by a director through dividend reinvestment signals continued alignment of management's interests with those of shareholders.

Key Dates

Recommendation

The filing reports a routine acquisition of shares by a director through dividend reinvestment, which is a positive signal of continued alignment with shareholder interests. However, it does not present new fundamental information to change an existing investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

DENTSPLY SIRONA, XRAY, insider transaction, Form 4, director ownership, equity acquisition, phantom stock, restricted stock units, dividends